SEATTLE, Aug. 6 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX:ONY), a
biotechnology company specializing in the development of innovative
therapeutic products for the treatment of cancer, today announced that it
intends to release its second quarter and year end 2009 financial results on
Wednesday, August 12, 2009 after the close of the U.S. and Canadian markets.
Following the release, Oncothyreon's management expects to discuss these
financial results and give a general business update in a conference call at
4:30 p.m. EST.
The discussion is planned for a live webcast and can be accessed at
www.oncothyreon.com under the "News & Events" section. It is expected that the
archive of the webcast will be available approximately one hour after
completion of the discussion and will be posted on the Oncothyreon website for
Oncothyreon is a biotechnology company specializing in the development of
innovative therapeutic products for the treatment of cancer. Oncothyreon's
goal is to develop and commercialize novel synthetic vaccines and targeted
small molecules that have the potential to improve the lives and outcomes of
cancer patients. For more information, visit www.oncothyreon.com.
For further information:
For further information: Investor and Media Relations Contact: Julie
Rathbun, Rathbun Communications, (206) 769-9219, firstname.lastname@example.org